On Tuesday, Integra Lifesciences Holdings Corp (NASDAQ: IART) was -0.92% drop from the session before settling in for the closing price of $17.32. A 52-week range for IART has been $16.96 – $45.42.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 1.17% over the past five years. When this article was written, the company’s average yearly earnings per share was at -20.99%. With a float of $65.06 million, this company’s outstanding shares have now reached $78.17 million.
Let’s look at the performance matrix of the company that is accounted for 5329 employees. In terms of profitability, gross margin is 56.92%, operating margin of 7.77%, and the pretax margin is 1.73%.
Integra Lifesciences Holdings Corp (IART) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Integra Lifesciences Holdings Corp stocks. The insider ownership of Integra Lifesciences Holdings Corp is 16.14%, while institutional ownership is 90.63%. The most recent insider transaction that took place on Aug 19 ’24, was worth 25,701. In this transaction SVP, Fin & Princ Acct Officer of this company sold 1,191 shares at a rate of $21.58, taking the stock ownership to the 36,088 shares. Before that another transaction happened on May 23 ’24, when Company’s Exec. Chairman of the Board bought 52,641 for $28.49, making the entire transaction worth $1,499,979. This insider now owns 487,922 shares in total.
Integra Lifesciences Holdings Corp (IART) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted 0.76 earnings per share (EPS) during the time that was less than consensus figure (set at 0.78) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.87 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -20.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.30% during the next five years compared to 3.10% growth over the previous five years of trading.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators
You can see what Integra Lifesciences Holdings Corp (IART) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.85. Likewise, its price to free cash flow for the trailing twelve months is 22.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.30, a number that is poised to hit 0.39 in the next quarter and is forecasted to reach 2.51 in one year’s time.
Technical Analysis of Integra Lifesciences Holdings Corp (IART)
Integra Lifesciences Holdings Corp (NASDAQ: IART) saw its 5-day average volume 1.08 million, a negative change from its year-to-date volume of 1.13 million. As of the previous 9 days, the stock’s Stochastic %D was 12.44%. Additionally, its Average True Range was 0.82.
During the past 100 days, Integra Lifesciences Holdings Corp’s (IART) raw stochastic average was set at 1.27%, which indicates a significant decrease from 4.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.26% in the past 14 days, which was lower than the 60.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.61, while its 200-day Moving Average is $32.62. Nevertheless, the first resistance level for the watch stands at $17.68 in the near term. At $18.21, the stock is likely to face the second major resistance level. The third major resistance level sits at $18.55. If the price goes on to break the first support level at $16.81, it is likely to go to the next support level at $16.47. Assuming the price breaks the second support level, the third support level stands at $15.94.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Key Stats
There are 78,800K outstanding shares of the company, which has a market capitalization of 1.33 billion. As of now, sales total 1,542 M while income totals 67,740 K. Its latest quarter income was 418,180 K while its last quarter net income were -12,400 K.
